Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design.

Gastroenterology. 2020 Sep 19;:

Authors: Abreu MT, Sandborn WJ, IOIBD Defining Endpoints and Biomarkers in Inflammatory Bowel Disease Writing Group

PMID: 32961246 [PubMed – as supplied by publisher]

Full Text Link: https://libkey.io/32961246